Sponsor or institution
Clinical trials and research at Cellergy Pharma
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $894,407 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Bispecific antibody to target IgE-producing B cells for allergy treatment
A new antibody therapy aims to selectively kill IgE-producing B cells to help people with severe allergic diseases feel better and reduce allergy symptoms.
-
Targeting IgE-producing B cells to treat allergic diseases
This study is testing a new antibody drug that aims to safely target and remove the B cells that cause allergies, with the hope of providing a lasting solution for people with severe allergic diseases.
-
Using CAR T cell therapy to treat severe allergic diseases.
This study is exploring a new way to help people with severe allergies by using a special treatment called CAR T cell therapy, which could provide lasting relief from allergy symptoms with just one treatment, instead of relying on medications that can have unwanted side effects.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.